ArticleScientific reports2025
Modulation of lipid composition and gene expression by CNP supplementation in in vitro cultured bovine embryos.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The objective of this study was to evaluate the effect of adding of C-Type Natriuretic (CNP) to the in vitro culture medium of bovine embryos on cryotolerability through modulation of lipid content and profile, as well as modulation of gene transcripts linked to embryonic metabolism. Initially, a concentration of 400 nM of CNP was used throughout the in vitro culture and blastocysts were collected for lipid content analysis by Sudan Black B. In addition, blastocysts were selected by morphological quality and developmental stage, and the samples collected were analyzed using MRM- profiling. After, blastocysts were vitrified using OPS. Subsequently the warming, hatched blastocysts were collected and evaluated for transcript abundance in a microfluidic platform. Differences of probabilities lower than P < 0.05, and/or fold change ˃1.5 were considered significant. The CNP group presented a reduction in the relative abundance of ions belonging to different lipid subclasses, such as acylcarnitine, sphingomyelin, cholesteryl esters, free fatty acids, and glycerophospholipid. Furthermore, the triacylglycerol lipids TG 52:3 NL 16:1, TG 56:3 NL 18:1, and the glycerophospholipid C22:6, were increased in the CNP group. A modulation of blastocyst transcripts was also observed by increased transcription of ATF4, and a trend statistical significance of BMP15 and GFPT2 transcripts. There was no difference in blastocyst development rates after warming of CNP-treated embryos.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.